Lighthouse Investment Partners’s Vertex Pharmaceuticals VRTX Stock Holding History

Lighthouse Investment Partners’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-9,000	Closed	-$4.2M	–	1089
2025 Q4	$4.08M	Buy	9,000 +6,500	+260%	+$2.8M	0.12%	229
2025 Q3	$979K	Buy	+2,500	New	+$1.04M	0.03%	447
2025 Q2	–	Sell	-1,800	Closed	-$873K	–	701
2025 Q1	$873K	Buy	+1,800	New	+$839K	0.04%	350
2024 Q4	–	Sell	-4,500	Closed	-$2.09M	–	656
2024 Q3	$2.09M	Sell	4,500 -10,888	-71%	-$5.23M	0.08%	251
2024 Q2	$7.21M	Buy	+15,388	New	+$6.68M	0.29%	97
2023 Q4	–	Sell	-10,644	Closed	-$3.7M	–	440
2023 Q3	$3.7M	Buy	+10,644	New	+$3.72M	0.15%	153

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Lighthouse Investment Partners's VRTX Position: Q1 2026 in Review

Lighthouse Investment Partners sold out of Vertex Pharmaceuticals (VRTX) in Q1 2026, closing a stake of 9,000 shares — an estimated $4.2M sold.

Lighthouse Investment Partners first reported a position in VRTX in Q3 2023 and held it in 6 quarters. The position peaked at $7.21M in Q2 2024. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

Lighthouse Investment Partners reported no remaining Vertex Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Lighthouse Investment Partners sold 9,000 Vertex Pharmaceuticals shares in Q1 2026, an estimated $4.2M.
Lighthouse Investment Partners first reported a position in Vertex Pharmaceuticals in Q3 2023 and held it in 6 quarters.
Lighthouse Investment Partners's Vertex Pharmaceuticals position peaked at $7.21M in Q2 2024.
1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Lighthouse Investment Partners's 13F filing for Q1 2026, filed 14 May 2026.